Tricuspid valve thrombus and pulmonary in an infant with homozygous thermolabile methylenetetrahydrofolate reductase and hetorozygous prothrombin G20210A variant

2Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We describe an unusual and interesting case of a full-term infant presenting at 7 days of life with HSV pneumonitis and a tricuspid valve thrombus ultimately requiring extracorporeal membrane oxygenation. The infant subsequently developed a pulmonary embolus. The infant was found to be heterozygous for the prothrombin G20210A mutation and homozygous for the methylenetetrahydrofolate reductase C667T mutation. The patient was treated with low molecular weight heparin for a total of 3 months and has not had a recurrent thrombosis. This case illustrates that a combination of congenital and acquired thrombophilic risk factors can contribute to a significant thrombotic event.

Cite

CITATION STYLE

APA

Thornburg, C. D., Lattimore, K. A., & Pipe, S. W. (2003). Tricuspid valve thrombus and pulmonary in an infant with homozygous thermolabile methylenetetrahydrofolate reductase and hetorozygous prothrombin G20210A variant. Journal of Perinatology, 23(6), 513–515. https://doi.org/10.1038/sj.jp.7210951

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free